07:00 , Jul 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1; β3GNT1); dystroglycan 1 (DAG1) Studies in mice and cell culture suggest that activating the β3GNT1 and DAG1 signaling pathways could help...